Abstract
Phase II study of Topotecan (TC) in patients (pts) with pretreated small-cell lung cancer (SCLC)
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have